🇨🇺 💉 Cuba has developed a second lung cancer vaccine.
VAXIRA is a theraputic lung cancer vaccine that works to help the immune system to destroy cancer cells. It has already shown major improvements in survival rates for lung cancer patients.
In 2011, Cuba developed CIMAvax-EGF the world’s first and only approved lung cancer vaccine. More than 5,000 people across the world have been treated with the vaccine. It costs just $1 to manufacture.
VAXIRA is a theraputic lung cancer vaccine that works to help the immune system to destroy cancer cells. It has already shown major improvements in survival rates for lung cancer patients.
In 2011, Cuba developed CIMAvax-EGF the world’s first and only approved lung cancer vaccine. More than 5,000 people across the world have been treated with the vaccine. It costs just $1 to manufacture.
31❤️2❤️1👀1💜1😎1
